{"id":15829,"date":"2020-04-23T11:23:21","date_gmt":"2020-04-23T15:23:21","guid":{"rendered":"https:\/\/medicarereport.org\/?p=15829"},"modified":"2020-04-23T11:23:21","modified_gmt":"2020-04-23T15:23:21","slug":"coronavirus-crisis-opens-access-to-online-opioid-addiction-treatment","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=15829","title":{"rendered":"Coronavirus Crisis Opens Access To Online Opioid Addiction Treatment"},"content":{"rendered":"

(By Phil Galewitz for Kaiser Health News)<\/p>\n

Opioid addiction isn\u2019t taking a break during the coronavirus pandemic.<\/p>\n

But the U.S. response to the viral crisis is making addiction treatment easier to get.<\/p>\n

Under the national emergency declared by the Trump administration in March, the government has suspended a federal law that required patients to have an in-person visit with a physician before they could be prescribed drugs that help quell withdrawal symptoms, such as Suboxone. Patients can now get those prescriptions via a phone call or videoconference with a doctor.\u00a0 Continue reading article here…<\/a><\/p>\n

Kaiser Health News is a nonprofit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation<\/p>\n

\"\"<\/a><\/p>\n

Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"
(By Phil Galewitz for Kaiser Health News) Opioid addiction isn\u2019t taking a break during the coronavirus pandemic. But the U.S.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15,33],"tags":[],"class_list":["post-15829","post","type-post","status-publish","format-standard","hentry","category-part-dprescription-drugs","category-telehealth"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/15829","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15829"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/15829\/revisions"}],"predecessor-version":[{"id":15830,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/15829\/revisions\/15830"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15829"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15829"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15829"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}